JPMorgan has initiated coverage of Odyssey Therapeutics with an Overweight rating, signaling a positive outlook for the company's stock.
Analyst ratings from major financial institutions like JPMorgan can influence investor sentiment and stock prices. An 'Overweight' rating suggests that JPMorgan analysts believe the stock will outperform the average stock in its sector or the broader market.
Analyst ratings from major financial institutions like JPMorgan can influence investor sentiment and stock prices. An 'Overweight' rating suggests that JPMorgan analysts believe the stock will outperform the average stock in its sector or the broader market.
Pick the topics you care about. Get only what matters, on your cadence.
Oracle: three option strategies for three market viewshome.saxoTrading stocks, CFDs, spread betting, futures, and options involves a high level of risk and may not be suitable for all investors. Prices can move rapidly, and losses can occur quickly and exceed your expectations.